Clinical-Genetic Features Influencing Disability in Spastic Paraplegia Type 4: A Cross-sectional Study by the Italian DAISY Network.
Journal
Neurology. Genetics
ISSN: 2376-7839
Titre abrégé: Neurol Genet
Pays: United States
ID NLM: 101671068
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
13
10
2021
accepted:
31
01
2022
entrez:
4
4
2022
pubmed:
5
4
2022
medline:
5
4
2022
Statut:
epublish
Résumé
Hereditary spastic paraplegias (HSPs) are a group of inherited rare neurologic disorders characterized by length-dependent degeneration of the corticospinal tracts and dorsal columns, whose prominent clinical feature is represented by spastic gait. Spastic paraplegia type 4 (SPG4, SPAST-HSP) is the most common form. We present both clinical and molecular findings of a large cohort of patients, with the aim of (1) defining the clinical spectrum of SPAST-HSP in Italy; (2) describing their molecular features; and (3) assessing genotype-phenotype correlations to identify features associated with worse disability. A cross-sectional retrospective study with molecular and clinical data collected in an anonymized database was performed. A total of 723 Italian patients with SPAST-HSP (58% men) from 316 families, with a median age at onset of 35 years, were included. Penetrance was 97.8%, with men showing higher Spastic Paraplegia Rating Scale (SPRS) scores (19.67 ± 12.58 vs 16.15 ± 12.61, The SPAST-HSP phenotypic spectrum in Italian patients confirms a predominantly pure form of HSP with mild-to-moderate disability in 75% of cases, and slight prevalence of men, who appeared more severely affected. Early-onset cases with intellectual disability were more frequent among patients carrying missense
Sections du résumé
Background and Objectives
UNASSIGNED
Hereditary spastic paraplegias (HSPs) are a group of inherited rare neurologic disorders characterized by length-dependent degeneration of the corticospinal tracts and dorsal columns, whose prominent clinical feature is represented by spastic gait. Spastic paraplegia type 4 (SPG4, SPAST-HSP) is the most common form. We present both clinical and molecular findings of a large cohort of patients, with the aim of (1) defining the clinical spectrum of SPAST-HSP in Italy; (2) describing their molecular features; and (3) assessing genotype-phenotype correlations to identify features associated with worse disability.
Methods
UNASSIGNED
A cross-sectional retrospective study with molecular and clinical data collected in an anonymized database was performed.
Results
UNASSIGNED
A total of 723 Italian patients with SPAST-HSP (58% men) from 316 families, with a median age at onset of 35 years, were included. Penetrance was 97.8%, with men showing higher Spastic Paraplegia Rating Scale (SPRS) scores (19.67 ± 12.58 vs 16.15 ± 12.61,
Discussion
UNASSIGNED
The SPAST-HSP phenotypic spectrum in Italian patients confirms a predominantly pure form of HSP with mild-to-moderate disability in 75% of cases, and slight prevalence of men, who appeared more severely affected. Early-onset cases with intellectual disability were more frequent among patients carrying missense
Identifiants
pubmed: 35372684
doi: 10.1212/NXG.0000000000000664
pii: NG2021017243
pmc: PMC8969300
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e664Informations de copyright
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
Références
J Neurol Neurosurg Psychiatry. 2009 Apr;80(4):440-3
pubmed: 19289482
Exp Neurol. 2014 Nov;261:518-39
pubmed: 24954637
Sci Rep. 2019 Oct 8;9(1):14412
pubmed: 31594988
Mov Disord. 2021 Jul;36(7):1644-1653
pubmed: 33576112
Neurology. 2004 May 25;62(10):1875-8
pubmed: 15159500
Arch Neurol. 2004 Jun;61(6):849-55
pubmed: 15210521
Hum Mol Genet. 2010 Jul 15;19(14):2767-79
pubmed: 20430936
BMC Neurol. 2014 Nov 25;14:216
pubmed: 25421405
Front Neurol. 2019 Jan 22;10:3
pubmed: 30723448
J Neurol Sci. 2020 Mar 15;410:116646
pubmed: 31887672
Neurogenetics. 2004 Sep;5(3):157-64
pubmed: 15248095
Front Neurol. 2019 Sep 18;10:967
pubmed: 31620065
J Neurol Sci. 2017 Sep 15;380:92-97
pubmed: 28870597
J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1073-8
pubmed: 20562464
Hum Mol Genet. 2006 Sep 15;15(18):2763-71
pubmed: 16893913
J Clin Invest. 2010 Apr;120(4):1097-110
pubmed: 20200447
Neurology. 2006 Jul 11;67(1):45-51
pubmed: 16832076
Lancet Neurol. 2019 Dec;18(12):1136-1146
pubmed: 31377012
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
J Neurol Neurosurg Psychiatry. 2008 May;79(5):606-7
pubmed: 17971434
J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):326-30
pubmed: 24046394
Nat Struct Mol Biol. 2019 Aug;26(8):671-678
pubmed: 31285604
Eur J Hum Genet. 2009 Feb;17(2):187-94
pubmed: 18701882
Brain. 2015 Sep;138(Pt 9):2471-84
pubmed: 26094131
Neurology. 2000 Sep 12;55(5):702-5
pubmed: 10980739
Neurol Genet. 2016 Dec 05;3(1):e122
pubmed: 27957547
J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):681-687
pubmed: 28572275
Neurology. 2006 Aug 8;67(3):430-4
pubmed: 16894103
J Neurol. 2015 Feb;262(2):476-8
pubmed: 25511172
Eur J Neurol. 2014 Jun;21(6):935-8
pubmed: 24824741
J Neurol Sci. 2005 Sep 15;236(1-2):9-12
pubmed: 16009377
Mov Disord. 2005 Aug;20(8):1055-9
pubmed: 15858810
Brain. 2014 Jul;137(Pt 7):1907-20
pubmed: 24833714
J Neurol Sci. 2011 Jul 15;306(1-2):62-5
pubmed: 21546041
Hum Mol Genet. 2002 Jan 15;11(2):153-63
pubmed: 11809724
Hum Mol Genet. 2000 Mar 1;9(4):637-44
pubmed: 10699187
Ann Neurol. 2016 Apr;79(4):646-58
pubmed: 26856398
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Ann Clin Transl Neurol. 2018 May 21;5(7):876-882
pubmed: 30009206
Lancet. 1983 May 21;1(8334):1151-5
pubmed: 6133167
Brain. 2018 Dec 1;141(12):3331-3342
pubmed: 30476002
Hum Mol Genet. 2014 May 15;23(10):2527-41
pubmed: 24381312
Acta Neuropathol. 2013 Sep;126(3):307-28
pubmed: 23897027
Neuroepidemiology. 2014;42(3):174-83
pubmed: 24603320
Life Sci Alliance. 2020 Oct 26;3(12):
pubmed: 33106322
Front Neurol. 2019 May 24;10:508
pubmed: 31231294
J Neurol. 2020 Feb;267(2):369-379
pubmed: 31646384
J Neurol. 2015 Aug;262(8):1961-71
pubmed: 26050637
J Neurol. 2021 Jun;268(6):2065-2082
pubmed: 31745725
Neurology. 2008 May 20;70(21):1959-66
pubmed: 18401025